Valuation: Cencora, Inc.

Market Cap 57.98B 51.16B 48.41B 43.9B 82.31B 5,563B 83.12B 581B 224B 2,841B 218B 213B 9,142B P/E 2026 *
16.6x
P/E 2027 * 18.2x
Enterprise Value 65.67B 57.95B 54.83B 49.72B 93.22B 6,301B 94.14B 658B 254B 3,218B 247B 241B 10,354B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.78%
Yield 2027 * 0.8%
1 day+1.65%
1 week-0.64%
Current month-3.71%
1 month-3.00%
3 months+6.13%
6 months-3.06%
Current year-15.80%
1 week 264.8
Extreme 264.8
272.4
1 month 264.8
Extreme 264.8
287.1
Current year 212.9
Extreme 212.9
316.5
1 year 212.9
Extreme 212.9
327.1
3 years 172.78
Extreme 172.78
327.1
5 years 101
Extreme 101
327.1
10 years 58.64
Extreme 58.644
327.1
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-0.75%-0.64% - - 57.98B
-0.03%-2.64%-24.16%+4.23% 175B
-2.69%-4.05%-7.32%+11.14% 114B
+1.25%-2.17%-0.15%+70.92% 57.98B
-1.01%-0.56%-1.10%-29.61% 50.07B
-1.00%+2.74%+13.85%+53.00% 50.13B
-0.05%-3.23%+30.36%-7.14% 32.71B
-0.26%+1.60% - - 30.77B
+0.26%+1.49%+44.68%+0.38% 26.44B
+0.28%+7.74%+26.61%-1.63% 23.96B
Average +0.04%+1.59%+10.35%+12.66% 62.36B
Weighted average by Cap. -0.33%-0.18%-3.05%+13.27%

Financials

2026 *2027 *
Net sales 337B 297B 281B 255B 478B 32,339B 483B 3,376B 1,301B 16,514B 1,265B 1,238B 53,141B 353B 311B 295B 267B 501B 33,870B 506B 3,536B 1,363B 17,295B 1,325B 1,297B 55,658B
Net income 3.58B 3.16B 2.99B 2.71B 5.08B 344B 5.13B 35.86B 13.82B 175B 13.44B 13.15B 565B 2.84B 2.51B 2.38B 2.15B 4.04B 273B 4.08B 28.5B 10.98B 139B 10.68B 10.45B 449B
Net Debt 7.69B 6.79B 6.42B 5.82B 10.92B 738B 11.03B 77.03B 29.69B 377B 28.88B 28.25B 1,213B 9.44B 8.33B 7.88B 7.15B 13.4B 905B 13.53B 94.52B 36.43B 462B 35.43B 34.66B 1,488B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
26-09-29 €264.80 -0.75%
26-09-28 €266.80 -1.84%
26-09-25 €271.80 +0.07%
26-09-24 €271.60 -0.29%
26-09-23 €272.40 -0.26%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
303.81USD
Average target price
369.25USD
Spread / Average Target
+21.54%

Quarterly revenue - Rate of surprise